Nurix Therapeutics, Inc.NRIXNASDAQ
LOADING
|||
EV to Sales History
Trending lower, below historical average, strong compound growth.
Left:
||||
Enterprise value to sales ratio
Latest
15.80
↓ 21% below average
Average (7y)
20.00
Historical baseline
Range
High:39.29
Low:4.08
CAGR
+11.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2025 | 15.80 | -38.5% |
| 2024 | 25.71 | +530.4% |
| 2023 | 4.08 | -71.3% |
| 2022 | 14.23 | -63.8% |
| 2021 | 39.29 | +27.6% |
| 2020 | 30.79 | +36.1% |
| 2019 | 22.61 | +201.8% |
| 2018 | 7.49 | - |